1500006I

Ended Awarded Last action

Contract number
HHSN27200002
Awardee
Awarding agency
Obligated
$416,540

Award facts

Opportunity
  • NIAIDDMIDNIHAI2013178 Solicitation number
Contract value 100% obligated
$416,539.69 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Durham, NC 27705, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 7 -$86,203
Supplemental Agreement for work within scope 6 $0
Supplemental Agreement for work within scope 5 $0
Supplemental Agreement for work within scope 4 $0
Supplemental Agreement for work within scope 3 $0
Supplemental Agreement for work within scope 2 $23,166
Supplemental Agreement for work within scope 1 $181,173
Original award $298,404

About this award

This is a cost-no-fee Delivery Order contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to Duke University for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The contract has a ceiling value of $416,539.69 and a period of performance through August 31, 2017. This order is part of a larger Therapeutics Against Infectious Diseases Phase 1 Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. No set-aside designation was used for this award to Duke University, which is a private non-profit university and educational institution. The contract involves clinical research services related to infectious disease therapeutics.

Quick answers

Who was awarded contract HHSN27200002?

HHSN27200002 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2015.

How much is contract HHSN27200002 worth?

The government has obligated $416,540 on HHSN27200002.

Is contract HHSN27200002 an order under another contract?

Yes. HHSN27200002 is a delivery order under HHSN272201500006I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.

Was contract HHSN27200002 competed?

The extent of competition for HHSN27200002 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award